Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Delays Final Rule on Allowing Generic Drug Makers to Update Labels
WSJ Pharmalot
Tuesday, November 18, 2014 - 10:10am
tags:
FDA, generics
Pfizer-Merck cancer deal reduces likelihood of AZ merger
Pharmaphorum
Tuesday, November 18, 2014 - 10:09am
tags:
Pfizer, Merck, AstraZeneca, M&A
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tuesday, November 18, 2014 - 10:06am
tags:
Orexigen, Europe, Contrave, obesity
Janssen Is Working Its Way Toward Anti-Obesity
Seeking Alpha
Tuesday, November 18, 2014 - 9:59am
tags:
Janssen, obesity, Invokana
Top drugmaker Novartis takes aim at tech
Yahoo/Reuters
Tuesday, November 18, 2014 - 9:46am
tags:
Novartis, Joe Jimenez, Wearable Medical Devices Market
Takeda Ordered to Pay $155,000 for Destroying Actos Files
Bloomberg
Tuesday, November 18, 2014 - 9:45am
tags:
Takeda, Actos
FDA puts partial hold on CytRx cancer drug trials
Yahoo/Reuters
Tuesday, November 18, 2014 - 9:09am
tags:
FDA, CytRx, clinical trials, aldoxorubicin
Actavis Surges to Top Drugmaker Ranks With Acquisitions
Bloomberg
Tuesday, November 18, 2014 - 8:44am
tags:
Actavis, M&A, Allergan
Zoetis unveils $500 million buyback plan
Marketwatch
Tuesday, November 18, 2014 - 8:39am
tags:
Zoetis, stock buyback, animal health
Ranbaxy Sues the FDA for Rescinding Approval of two Generic Drugs
WSJ Pharmalot
Tuesday, November 18, 2014 - 8:29am
tags:
Ranbaxy, generics, FDA, Valcyte, Nexium
Medtronic profit meets expectations; Covidien deal on track
Yahoo/Reuters
Tuesday, November 18, 2014 - 8:27am
tags:
Medtronic, earnings, M&A, Covidien, devices
AstraZeneca trumpets solo strength in cancer drugs post Pfizer struggle
Yahoo/Reuters
Tuesday, November 18, 2014 - 8:26am
tags:
AstraZeneca, Pfizer
Docs Were Concerned Valeant Would Acquire Allergan: Survey
WSJ Pharmalot
Monday, November 17, 2014 - 4:42pm
tags:
Allergan, Actavis, Valeant Pharmaceuticals, M&A, physicians
2 Skyrocketing Biotech Stocks In A Stalling Market
Yahoo/Benzinga
Monday, November 17, 2014 - 4:40pm
tags:
Orexigen, Achillion
Juno takes its hot CAR-T cancer tech to Wall Street in $150M IPO
Fierce Biotech
Monday, November 17, 2014 - 4:07pm
tags:
Juno Therapeutics, CAR-T, cancer, IPOs
Incyte Building Blockbuster Drug One Disease At A Time
Investors.com
Monday, November 17, 2014 - 4:05pm
tags:
Incyte, Jakafi, myelofibrosis
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Monday, November 17, 2014 - 4:03pm
tags:
Merck, Vytorin, Amgen, Regeneron
Report: Medtronic readies $10B bond flotation for Covidien deal
Mass Device
Monday, November 17, 2014 - 10:58am
tags:
Medtronic, Covidien, M&A, devices
Neuro Kinetics wins NFL grant for brain-injury detector
Mass Device
Monday, November 17, 2014 - 10:56am
tags:
Neuro Kinetics, brain injury, NFL, grants, I-Portal PAS, devices
Adexanet Alfa reverses anticoagulant effect of Eliquis in first stage of Phase 3
Seeking Alpha
Monday, November 17, 2014 - 10:55am
tags:
Eliquis, bloodthinners, Adexanet Alfa, Portola Pharmaceuticals, Pfizer, Bristol-Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.